Russia to start administering its first antiviral drug approved to treat coronavirus patients next week, state funding agency told Reuters, a move it described as “a game-changer” that should speed up the return to a normal economic life.
Russian hospitals can start giving the drug to patients from June 11, with enough to treat around 60,000 people a month, the head of the Russian sovereign fund RDIF told Reuters.
Registered as Avifavir, it is the first potential treatment for coronaviruses to be approved by the Russian Ministry of Health. He appeared on a government list of approved drugs on Saturday after clinical trials.
RDIF director Kirill Dmitriev said that the clinical trials involved 330 people and showed that the drug succeeded in treating the virus in most cases within four days.
Your email address will not be published. Required fields are marked *